Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-05-01

Clinical Trial Update: Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

View source ↗

Summary

A clinical trial update examining the role of antibodies against glutamate receptors and double-stranded DNA in epilepsy patients. The study status is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Epilepsy | Status: UNKNOWN